For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220425:nRSY2734Ja&default-theme=true
RNS Number : 2734J IP Group PLC 25 April 2022
FOR RELEASE ON 25 APRIL 2022
IP Group plc - DBSP awards; Director/PDMR shareholding
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"),
which develops world-changing science and technology businesses across life
sciences, technology and cleantech, announces the following in connection with
its employee share schemes.
Deferred Bonus Share Plan ("DBSP") Awards
IP Group has granted nil-cost options over ordinary shares of two pence each
("Shares") to the executive directors and persons discharging managerial
responsibilities ("PDMRs") under the Group's DBSP on 21 April 2022. The grants
reflect the deferral of fifty per cent of each person's award above £25,000
under the Group's Annual Incentive Scheme ("AIS") in respect of the Group's
performance for the financial year ended 31 December 2021. The following table
sets out details of the awards made to the Executive Directors and PDMRs:
Name of Director/PDMR Structure of award Number of options granted Total number of options currently held
Greg Smith Nil-Cost Option 176,200 298,403
David Baynes Nil-Cost Option 150,902 269,013
Sam Williams Nil-Cost Option 82,364 153,086
Mark Reilly Nil-Cost Option 94,736 160,210
Angela Leach Nil-Cost Option 58,224 102,758
Christopher Glasson Nil-Cost Option 41,088 64,980
Lisa Patel Nil-Cost Option 3,680 5,970
Liz Vaughan-Adams Nil-Cost Option 38,272 52,664
Moray Wright Nil-Cost Option 84,876 88,260
Dan Xie Nil-Cost Option 29,790 44,874
Anthony York Nil-Cost Option 33,498 33,498
Total 793,630 1,273,716
In addition to the above, awards over a total of 1,272,544 Shares were made to
certain other of the Group's employees. As at the date of this announcement, a
total of 3,377,871 nil-cost options over Shares remain outstanding under the
IP Group DBSP.
No consideration was paid for the grant of the awards and no consideration is
due on the maturity of the option period. Fifty per cent of the options will
normally be automatically exercised on 31 March 2023 and fifty per cent on 31
March 2024, with each such automatic exercise generally subject to continued
employment.
Shares in issue
At the date of this announcement, the Company continues to have 1,063,033,287
Shares in issue and 28,938,473 Shares held in treasury.
The following information is being disclosed pursuant to the requirements of
MAR.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.
DBSP awards
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Greg Smith
David Baynes
Sam Williams
Mark Reilly
Angela Leach
Christopher Glasson
Lisa Patel
Liz Vaughan-Adams
Moray Wright
Dan Xie
Anthony York
2 Reason for the notification
a) Position/status Director Chief Executive Officer
Director Chief Operating and Financial Officer
PDMR Managing Partner, Life Sciences
PDMR Managing Partner, Technology
PDMR General Counsel & Company Secretary
PDMR Finance Director
PDMR Partner, Employee Executive
PDMR Director of Communications
PDMR CEO Parkwalk
PDMR Partner, Employee Executive
PDMR Group People Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name IP Group plc
b) Legal Entity Identifier 213800HG22UM138WFG43
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 2p each in IP Group plc
Identification code
ISIN: GB00B128J450
b) Nature of the transaction Grant of nil-cost options under the IP Group plc DBSP
c) Currency GBP
d) Price(s) and volume(s) Name(s) Price(s) Volume(s)
Greg Smith Nil cost option 176,200
David Baynes Nil cost option 150,902
Sam Williams Nil cost option 82,364
Mark Reilly Nil cost option 94,736
Angela Leach Nil cost option 58,224
Christopher Glasson Nil cost option 41,088
Lisa Patel Nil cost option 3,680
Liz Vaughan-Adams Nil cost option 38,272
Moray Wright Nil cost option 84,876
Dan Xie Nil cost option 29,790
Anthony York Nil cost option 33,498
e) Aggregated information
-Aggregated volume Aggregated number of options granted under the DBSP to Directors and PDMRs on
21 April 2022: 793,630
- Price
Price: £ nil
- Aggregated total
f) Date of the transaction 21 April 2022
g) Place of the transaction Outside a trading venue
e)
Aggregated information
-Aggregated volume
- Price
- Aggregated total
Aggregated number of options granted under the DBSP to Directors and PDMRs on
21 April 2022: 793,630
Price: £ nil
f)
Date of the transaction
21 April 2022
g)
Place of the transaction
Outside a trading venue
For more information, please contact:
IP Group plc www.ipgroupplc.com (http://www.ipgroupplc.com)
Liz Vaughan-Adams, Communications +44 (0) 20 7444 0062/+44 (0) 7979 853802
Charlotte Street Partners
David Gaffney +44 (0) 7854 609998
Andrew Wilson +44 (0) 7810 636995
Notes for editors
About IP Group
IP Group develops world-changing science and technology businesses across life
sciences, technology and cleantech. The Group has a strong track record of
success, having been the founder investor in a number of high-profile
companies including Oxford Nanopore Technologies plc, and has one of the most
exciting portfolios of high-growth businesses in Europe. The Group also owns
Parkwalk, the UK's largest growth EIS fund manager which backs world-changing
technologies emerging from the UK's leading universities and research
institutions. IP Group is listed on the Main Market of the London Stock
Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUVRBRUWUSUAR